Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid- 1-42 Oligomers Are Revealed In Vivo by Using a Novel Animal ModelJonathan Brouillette, Luc Buée|Journal of Neuroscience|2012Cited by 171
Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomersJulien Dufort‐Gervais, Jonathan Brouillette|Scientific Reports|2020Cited by 50
Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in ratsAudrey Hector, Jonathan Brouillette|Alzheimer s Research & Therapy|2023Cited by 13